Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants

Pediatrics

Volumn 114, Issue 4, 2004, Pages 917-924

  Suresh, Gautham K ^a,c   Clark, Robin E ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bilirubin; Cost; Cost effectiveness; Infant; Jaundice; Kernicterus; Newborn; Screening

Indexed keywords

ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FOLLOW UP; HEALTH CARE COST; HEALTH CARE POLICY; HOME CARE; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; LABORATORY TEST; MODEL; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; RISK; BLOOD; BLOOD ANALYSIS; BLOOD EXAMINATION; COST BENEFIT ANALYSIS; DECISION TREE; ECONOMICS; HOSPITAL CHARGE; PHOTOTHERAPY; QUALITY ADJUSTED LIFE YEAR;

BILIRUBIN;

BILIRUBIN; BLOOD CHEMICAL ANALYSIS; COST-BENEFIT ANALYSIS; DECISION TREES; HEALTH CARE COSTS; HEMATOLOGIC TESTS; HOSPITAL CHARGES; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; KERNICTERUS; PHOTOTHERAPY; QUALITY-ADJUSTED LIFE YEARS;

EID: 16644370835     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-0899     Document Type: Article

References (24)

1. Johnson LH, Bhutani VK. System based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396-403
2. American Academy of Pediatrics Subcommittee on Neonatal Hyperbilirubinemia. Neonatal jaundice and kernicterus. Pediatrics. 2001;108:763-765
3. Newman TB, Maisels JM. Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines. Pediatrics. 2000;105:242-245
4. Joint Commission on Accreditation of Healthcare Organizations. Sentinel Event Alert. Oak Brook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 2001
5. Centers for Disease Control and Prevention. Kernicterus in full term infants-United States, 1994-1998. MMWR Morb Mortal Wkly Rep. 2001;50:491-494
6. American Academy of Pediatrics. Provisional committee for quality improvement and subcommittee on hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics. 1994;94:1122-1132
7. American Academy of Pediatrics. Provisional committee for quality improvement and subcommittee on hyperbilirubinemia. Pediatrics. 2004;114:297-316
8. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6-14
9. Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial pre-discharge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106(2). Available at: www.pediatrics.org/cgi/content/full/106/2/e17
10. Galbraith AA, Egerter SA, Marchi KS, Chavez G, Braveman PA. Newborn early discharge revisited: are California newborns receiving recommended postnatal services? Pediatrics. 2003;111:364-371
11. Maisels MJ, Kring E. Early discharge from the newborn nursery - effect on scheduling of follow-up visits by pediatricians. Pediatrics. 1997;100:72-74
12. Lieu TA, Wikler C, Capra AM, Martin KE, Escobar GJ, Braveman PA. Clinical outcomes and maternal perceptions of an updated model of perinatal care. Pediatrics. 1998;102:1437-1444
13. Petrova A, Mehta R, Ostfeld B, Scharf R, Hegyi T. New Jersey pediatricians' hyperbilirubinemia and kernicterus practice survey. Pediatr Res. 2004;55(suppl):378A (abstr)
14. Newman TB, Escobar GB, Gonzales VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104:1198-1203
15. Meara E, Kotagal U, Atherton HD, Lieu TA. Impact of early newborn discharge legislation and early follow-up visits on infant outcomes in a state medicaid population. Pediatrics. 2004;113:1619-1627
16. Madden JM, Soumerai SB, Lieu TA, Mandl KD, Zhang F, Ross-Degnan D. Length-of-stay policies and ascertainment of postdischarge problems in newborns. Pediatrics. 2004;113:42-49
17. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2003 rates. Final rule. Fed Regist. 2002;67:49981-50289
18. Centers for Disease Control and Prevention. Economic costs associated with mental retardation, cerebral palsy, hearing loss and vision impairment -United States 2003. MMWR Morb Mortal Wkly Rep. 2004;53:57-59
19. Waitzman NJ, Scheffler RM, Romano PS. The Cost of Birth Defects: Estimates of the Value of Prevention. Lanham, MD: University Press of America; 1996:4
20. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140-1147
21. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics. 2003;111:1303-1311
22. Centers for Disease Control and Prevention. Kernicterus research activities - UMDNJ-Robert Wood Johnson Medical School Kernicterus Research and Prevention Center. Available at: www.cdc.gov/ncbddd/dd/kernres.htm. Accessed July 1, 2004
23. Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001;107:1-13
24. Teutsch SM, Haddix AC. Decision analysis for public health. In: Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention Effectiveness. A Guide to Decision Analysis and Economic Evaluation. New York, NY: Oxford University Press; 1996:52